Stifel Financial Corp Sells 2,737 Shares of National Research Co. (NASDAQ:NRC)

Stifel Financial Corp decreased its position in shares of National Research Co. (NASDAQ:NRC) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,433 shares of the company’s stock after selling 2,737 shares during the quarter. Stifel Financial Corp’s holdings in National Research were worth $673,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp raised its position in shares of National Research by 5.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 123,255 shares of the company’s stock valued at $2,829,000 after buying an additional 6,295 shares in the last quarter. Rhumbline Advisers raised its position in National Research by 4.3% during the second quarter. Rhumbline Advisers now owns 21,453 shares of the company’s stock valued at $492,000 after purchasing an additional 892 shares in the last quarter. American Century Companies Inc. lifted its stake in National Research by 13.3% during the second quarter. American Century Companies Inc. now owns 31,231 shares of the company’s stock worth $717,000 after purchasing an additional 3,657 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of National Research by 14.4% in the 2nd quarter. Renaissance Technologies LLC now owns 432,884 shares of the company’s stock valued at $9,935,000 after purchasing an additional 54,600 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of National Research by 145.6% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after purchasing an additional 1,650 shares during the last quarter. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Price Performance

National Research stock opened at $17.76 on Thursday. The stock has a fifty day moving average of $18.88 and a 200-day moving average of $21.28. The stock has a market capitalization of $416.93 million, a P/E ratio of 15.72 and a beta of 0.52. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research Co. has a 52 week low of $16.74 and a 52 week high of $42.18.

National Research (NASDAQ:NRC) last issued its earnings results on Friday, October 25th. The company reported $0.24 EPS for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The firm had revenue of $35.82 million during the quarter.

National Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be given a $0.12 dividend. The ex-dividend date is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.70%. National Research’s dividend payout ratio is currently 42.48%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.